[Federal Register Volume 80, Number 29 (Thursday, February 12, 2015)] [Notices] [Page 7871] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2015-02909] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2015-N-0001] Advisory Committee Renewals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed in the following table for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed in the following table. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app.). DATES: Authority for these committees will expire on the dates indicated in the following table unless the Commissioner formally determines that renewal is in the public interest. ------------------------------------------------------------------------ Name of committee Date of expiration ------------------------------------------------------------------------ Cardio and Renal Drugs Advisory Committee. August 27, 2016. Endocrinologic and Metabolic Drugs August 27, 2016. Advisory Committee. Oncologic Drugs Advisory Committee........ September 1, 2016. Anti-Infective Drugs Advisory Committee... October 7, 2016. Dermatologic and Ophthalmic Drugs Advisory October 7, 2016. Committee. Cellular, Tissue, and Gene Therapies October 28, 2016. Advisory Committee. Technical Electronic Product Radiation December 24, 2016. Safety Standards Committee. ------------------------------------------------------------------------ FOR FURTHER INFORMATION CONTACT: Michael Ortwerth, Director, Advisory Committee Oversight and Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-443-0572 or 1-800-741-8138. For further information related to FDA advisory committees, please visit us at http://www.fda.gov/AdvisoryCommittees/default.htm. Dated: February 6, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015-02909 Filed 2-11-15; 8:45 am] BILLING CODE 4164-01-P